Ultrasonographic Evaluation of Talar Cartilage Thickness in Patients With Spinal Cord Injury

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

76 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-20

Study Completion Date

2026-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Spinal cord injury patients often present with musculoskeletal comorbidities, including osteoarthritis. Early detection of cartilage damage is important for preventing osteoarthritis progression. This study aims to compare the talar cartilage thicknesses of spinal cord injury patients with healthy subjects. The secondary aim is to investigate a correlation between the talar cartilage thickness and disease-related parameters. The patient group is to be assessed for talar cartilage thickness (via ultrasound), functional status, spasticity, and ambulation levels.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spinal Cord Injuries (SCI) Osteoarthritis (OA)

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

spinal cord injury osteoarthritis musculoskeletal ultrasound talar cartilage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient group

Spinal cord injury patients

No interventions assigned to this group

Control group

Age, sex, and BMI matched healthy controls

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged between 18 to 60 years,
* Cervical, thoracal or lumber level of spinal cord injury
* AIS (American Spinal Injury Association Impairment Scale) Level A, B, C, or D
* Assisted ambulation of any kind
* Literacy
* Giving oral and written consent to participate in the study

Exclusion Criteria

* Patients with sacral level injury
* AIS E
* MAS 4 level of spasticity
* History of any lower extremity operation
* History of fracture
* Botulinum toxin injection in the last 6 months
* Existing diagnosis of any rheumatologic or endocrine diseases

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gaziosmanpasa Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ebru Alanbay-Yağcı

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

172

Identifier Type: -

Identifier Source: org_study_id